Plattsburgh, NY, 2018-Jun-25 — /EPR Network/ — Post-operative pulmonary complications (PPCs) are a major burden to the healthcare system. A new real-world study published in [read full press release…]
Aerobika® OPEP device proves to be a cost-effective treatment option in the management of post-exacerbation COPD patients. Plattsburgh, NY, 2017-Nov-11 — /EPR Network/ — The [read full press release…]
This latest study adds to the growing base of evidence that demonstrates Monaghan’s drug-free Aerobika® device is effective for lung health maintenance. Syracuse, NY, 2017-Jan-17 [read full press release…]
